Camping experience for children with cancer
Official title: Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Run by National Institutes of Health Clinical Center (CC) · NCT00001186 · Data updated 2026-11-12
This study tests whether a camping experience can help children with cancer feel better and build confidence while they are undergoing treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 25 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | February 15, 1983 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT00001186 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 7-17 currently receiving treatment for cancer or young adults aged 18-25 acting as counselors.
✕Probably not a fit
Patients who are not currently undergoing treatment or are outside the specified age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the psychological and social benefits of a normalized camping experience for children with cancer, aiming to enhance their quality of life and self-esteem. It involves children aged 7-17 currently undergoing cancer treatment or young adults aged 18-25 serving as counselors. The camping experience is designed to help these children develop skills of independence and separation from their medical environments. The study will assess both short and long-term impacts on the participants' well-being and attitudes.
Why it matters
Potential benefit: If successful, this could significantly improve the psychological well-being and self-esteem of children with cancer.
How similar studies have gone: While this approach is innovative, similar studies have shown positive outcomes in psychosocial interventions for pediatric cancer patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: * Children 7-17 years of age who are currently being treated for cancer or are up to 5 years post therapy. OR Young adults with cancer (YACers) 18-25 years of age who are acting as counselors at Camp Fantastic. * Children/young adults will be selected for camp after careful screening by a multidisciplinary committee consisting of medical and program directors. While the state of the child s health will certainly be considered there will be no exclusions for: * Patients who are receiving intramuscular, intrathecal, oral or intravenous medications or blood products. * Patients who have had amputations or have other physical defects. * Patients who become febrile and neutropenic at the onset or during the week of camp will stay at camp on antibiotic therapy providing their condition remains stable. * At the discretion of the multidisciplinary committee consisting of medical and program directors, special exceptions may be made for patients with extenuating circumstances. * All children will be officially enrolled and will have an NIH Clinical Center Patient Care Number. The enrollment of a child, signing of protocol consent, and completion of admission paperwork is done in person but under extenuating circumstances it may be done over the phone after the paperwork has been mailed to the parent/guardian. Extenuating circumstances would include a last minute application to camp after the trip for camp screenings in Norfolk or Richmond has been completed. EXCLUSION CRITERIA: -Children with a medical diagnosis other than cancer or their related disorders.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: John F Shern, M.D. — National Cancer Institute (NCI)
- Study coordinator: Tammara L Jenkins, R.N.
- Email: tjenkins@mail.nih.gov
- Phone: (240) 760-6550
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.